Position in ANNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$58,921,488
+$7,604,690 QoQ
Shares Held
10,635,648
+4.0% QoQ
Ownership
5.33%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 99.87673529624146.ToString("F0")%
Shared 0.ToString("F0")%
None 0.12326470375852981.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. ANNX ranks #97 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in ANNX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $111,450,612 | 19,518,496 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $58,921,488 | 10,635,648 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $51,316,798 | 10,222,470 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $33,797,545 | 11,081,163 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $37,668,539 | 15,695,226 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $25,596,292 | 13,262,328 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $72,971,083 | 14,224,383 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $50,686,737 | 8,561,949 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $40,668,627 | 8,299,720 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $67,203,132 | 9,372,822 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $43,971,719 | 9,685,401 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $216,604 | 91,782 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,946,577 | 1,405,278 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,504 | 1,170 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $6,059 | 1,172 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,279 | 1,178 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $4,738 | 1,257 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $216,007 | 79,124 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $15,396,907 | 1,340,027 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $39,181,902 | 2,105,422 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $44,575,359 | 1,980,247 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $65,343,625 | 2,347,113 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $55,088,200 | 2,200,887 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $66,680,002 | 2,205,756 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||